More Press Releases

View Older Stories View Newer Stories

Dec 9, 2024 07:00AM Apax Funds to Sell Minority Stake in AssuredPartners to Arthur J. Gallagher & Co.
Dec 9, 2024 07:00AM New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) Presented at the 2024 American Society of Hematology Meeting
Dec 9, 2024 07:00AM LOMOND THERAPEUTICS REPORTS RESULTS FROM ONGOING CLINICAL STUDIES OF LONITOCLAX, A SELECTIVE BCL-2 INHIBITOR WITH BEST-IN-CLASS SELECTIVITY VERSUS BCL-XL AND NO CYP 3A4 LIABILITY
Dec 9, 2024 07:00AM Secura Bio Presented New Data from its Phase 2 PRIMO Trial of Copiktra® (Duvelisib) in Relapsed or Refractory Peripheral T-cell Lymphoma and Announced Plans for its Phase 3 TERZO Trial at the 2024 Am
Dec 9, 2024 07:00AM GTCR Announces Sale of AssuredPartners to Arthur J. Gallagher & Co. for $13.45 Billion
Dec 9, 2024 07:00AM Nusano and GlyTherix Announce Lutetium-177 Supply Agreement
Dec 9, 2024 07:00AM Riot Platforms Announces Proposed Private Offering of $500 Million of Convertible Senior Notes
Dec 9, 2024 07:00AM Aircastle Delivers the First of Six 737MAX9 Aircraft to United Airlines
Dec 9, 2024 07:00AM Datadog Announces Proposed Private Offering of $775 Million of Convertible Senior Notes
Dec 9, 2024 07:00AM FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
Dec 9, 2024 07:00AM Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients
Dec 9, 2024 07:00AM VERSABANK DECLARES DIVIDENDS
Dec 9, 2024 07:00AM CVS Health Corporation Announces Expiration and Results of Any and All Tender Offer
Dec 9, 2024 07:00AM Movement Network Foundation Announces Launch of Movement Mainnet Beta and $MOVE Token Generation Event
Dec 9, 2024 07:00AM InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)
Dec 9, 2024 07:00AM VERSABANK FOURTH QUARTER AND FISCAL 2024 RESULTS CONTINUE TO DEMONSTRATE STRENGTH OF BUSINESS MODEL AS BANK LAUNCHES PROVEN RPP SOLUTION IN US MARKET
Dec 9, 2024 07:00AM Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
Dec 9, 2024 07:00AM Houston METRO awards NFI subsidiary MCI 100 D45 CRT commuter coaches
Dec 9, 2024 07:00AM Wayfair Professional Unveils 2025 Design Trends
Dec 9, 2024 07:00AM Startup World Cup 2025 CES Las Vegas - Win $1M Investment Prize!
Dec 9, 2024 07:00AM Auron Presents New Preclinical Data for AUTX-703 in AML at ASH Annual Meeting
Dec 9, 2024 07:00AM Lodging Dynamics Hospitality Group Welcomes Hospitality Veteran Lisa Carlson as Chief Operating Office
Dec 9, 2024 07:00AM Chorus One Joins Northstake's ETH Validator Marketplace As Node Operator
Dec 9, 2024 07:00AM BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
Dec 9, 2024 07:00AM Media Alert: NightWare Launches Campaign to Disrupt Sleep
Dec 9, 2024 07:00AM Sunoco LP Announces 2025 Operational and Financial Guidance and Participation in Upcoming Mizuho Power, Energy & Infrastructure Conference
Dec 9, 2024 07:00AM Iron Mountain announces the election of June Yee Felix to the Board of Directors
Dec 9, 2024 07:00AM Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
Dec 9, 2024 07:00AM Barington Capital Group Calls on Macy’s to Make Changes to Its Capital Allocation Plan to Improve Shareholder Value
Dec 9, 2024 07:00AM Remote Revolutionizes Hiring with AI That Finds the Best Global Talent Seamlessly
Dec 9, 2024 07:00AM Datopotamab deruxtecan granted breakthrough therapy designation in US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
Dec 9, 2024 07:00AM Siyata Mobile's Versatile Bluetooth Remote Speaker Mic Gaining Sales Momentum
Dec 9, 2024 07:00AM EARTHDAY.ORG RELEASES THE FIRST-OF-ITS-KIND LIVE TRACKER: MONITORING THE STATUS OF CLIMATE EDUCATION IN NATIONALLY DETERMINED CONTRIBUTIONS (NDCs) ACROSS THE WORLD
Dec 9, 2024 07:00AM Flow Beverage Corp. to Attend ROTH Deer Valley Event December 11-14, 2024
Dec 9, 2024 07:00AM DeepGreenX Group and Hues Capital Launch $10 Billion USD Fund to Accelerate AI, Green Energy, and Computing Power
Dec 9, 2024 07:00AM Kinaxis Offers a Solution to Streamline Bel’s Supply Chain
Dec 9, 2024 07:00AM Hamilton Lane Named a 'Best Place to Work in Money Management' For the 13th Consecutive Year by Pensions & Investments
Dec 9, 2024 07:00AM Seismic Therapeutic Presents New Preclinical Efficacy Data for S-1117 in Prophylactic and Therapeutic Animal Models of Immune Thrombocytopenia (ITP) at 66th ASH Annual Meeting
Dec 9, 2024 07:00AM Lattice Semiconductor Announces Additional $100 Million Stock Repurchase Program Authorization
Dec 9, 2024 07:00AM CitiusTech Awarded a 2024 AWS Partner Award
Dec 9, 2024 07:00AM McDermott Completes CB&I Divestment to Consortium of Investors led by Mason Capital Management
Dec 9, 2024 07:00AM Newpark Resources Announces New Brand Identity, Aligning Strategic Focus on Specialty Rental Solutions for the Global Worksite Access Market
Dec 9, 2024 07:00AM Air Industries Group Secures $11 Million Contract for Landing Gear Assemblies for the US Navy E-2D Advanced Hawkeye Aircraft
Dec 9, 2024 07:00AM ICE Expands Global Energy Offering with the Launch of Japanese Power Futures
Dec 9, 2024 07:00AM Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting
Dec 9, 2024 07:00AM Denodo Named a Leader in the 2024 Gartner® Magic Quadrant™ for Data Integration Tools for Five Consecutive Years
Dec 9, 2024 07:00AM CytoSorbents Announces Rights Offering
Dec 9, 2024 07:00AM Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
Dec 9, 2024 07:00AM Coherent Signs Preliminary Memorandum of Terms With The U.S. Department of Commerce to Expand the World’s First 150 mm Indium Phosphide Manufacturing Line
Dec 9, 2024 07:00AM Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor
View Newer Stories View Older Stories